News

ReCor Medical Paradise System Renal Denervation RDN Therapy Hypertension

ReCor Medical advanced its Paradise System for renal denervation (RDN) for treatment resistant ...

SHEA Infection Control General Cardiology CT Systems White Coats

The Society for Healthcare Epidemiology of America (SHEA), an infection control organization, issued voluntary...

Cour Pharmaceutical Development Co. Inc. published data in Science Translational Medicine showing the potential of Immune Modifying Nanoparticles (IMP) to reduce inflammation...

Icahn Mount Sinai HDL LDL Nanotherapy Stem Cell Therapies Cath Lab

An international research team, led by Icahn School of Medicine at Mount Sinai investigators, designed and tested a high-density lipoprotein (HDL) nanoparticle loaded with a statin drug. In mouse...

An international research team at Icahn School of Medicine at Mount Sinai is testing a sugar-based tracer ...

Reva Medical ReZolve2 Bioresorbable Scaffold Stent Clinical Trial

An implant of the ReZolve2 bioresorbable scaffold was transmitted live via satellite at the Transcatheter...

Carotid Stent Clinical Study Abbott Cordis National Cardiovascular Data Registry

The three most common systems to place stents in blocked carotid arteries of the neck have similarly low rates of...

Computed Tomography (CT) procedure rates have declined by an average annual 5.5 percent in the United States over the...

mri systems clinical trial study university pennsylvania creatine CEST map

A new magnetic resonance imaging (MRI) method to map creatine at higher resolutions in the heart may help...

heart valve repair clinical trial study edwards lifesciences sapien 3

Edwards Lifesciences Corp. announced that it received investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to initiate a clinical trial of the Sapien 3...

hypertension therapies cvrx barostim neo therapy

CVRx Inc. announced findings from a health-economic analysis published in the Journal of Hypertension that indicates Barostim Therapy is a cost-effective treatment option for...

Medtronic, symplicity, renal denervation

Medtronic Inc. announced its U.S. pivotal trial for its Symplicity renal denervation system to treat resistant hypertension, the SYMPLICITY HTN-3 trial, failed to meet its primary efficacy...

clinical trial study irhythm holter monitors zio report patch ecg ep lab

iRhythm Technologies announced that a prospective study by Scripps Translational Science Institute (STSI) has found that use of...

stentys self-apposing stent clinical trial study TCT 2013 cath lab

Stentys, developer of the world's first self-apposing stent to treat acute myocardial infarction (AMI), announced...

The American College of Cardiology (ACC) has established the PINNACLE Registry Research Alliance to connect cardiovascular care teams with information about ...

medtronic symplicity renal denervation therapy hypertension cath lab trial study

Medtronic Inc. announced that the first patients were randomized in Symplicity HTN-4, which will evaluate the Symplicity ...

Massachusetts was on the same brink in 2006 that the entire nation is on today: the brink of expanding health insurance to cover far more people than before through government-driven, market-based...

 A study published in the Journal of the American Heart Association revealed findings...

study shows that coronary artery calcium (CAC) screening, an assessment tool that is not currently...